Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Prostate Cancer

Apalutamide Preserves HRQoL in Metastatic Castration-Sensitive Prostate Cancer

Neeraj Agarwal, MD, discusses the TITAN trial and the implications in prostate cancer treatment.
Read More >>

Coupling Novel Approaches With Chemo in Advanced Prostate Cancer

Genetic Testing Gains Increasingly Significant Role in Prostate Cancer

Targeted High-Dose Radiation Improves PFS, Progression in Oligometastatic Prostate Cancer

FDA Grants Niraparib Breakthrough Designation for BRCA+ mCRPC

ESMO 2019: Cabazitaxel Emerges as Third-Line Standard for Metastatic CRPC

View More Stories >>

View Conference Coverage

2019 Hairy Cell Leukemia Foundation Annual Conference

2019 Lynn Sage Breast Cancer Symposium

2019 ESMO Congress

17th International Myeloma Workshop

2019 Society of Hematologic Oncology Annual Meeting

Dr. Giri on the PROGRESS Registry for Genetic Testing in Prostate Cancer

Dr. George on the Changing Treatment Landscape in Prostate Cancer

Dr. Pettaway on Importance of Inclusive Germline Testing in Prostate Cancer

Dr. Concepcion on Barriers to Genetic Testing in Community Urology Practices

Dr. George on Investigational Agents Downstream of the Androgen Receptor in Prostate Cancer

Dr. Giri on Increasing Awareness of Genetic Testing in Prostate Cancer

Dr. Hussain on Results of the PROfound Trial in mCRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Role of PARP Inhibitors in Prostate Cancer

Considerations for Genetic Testing in Prostate Cancer

Sequencing in Nonmetastatic and Metastatic CRPC

Patient Selection for Radium-223 in mCRPC

Reducing Risk of Fracture in Metastatic CRPC

AR-V7 as a Predictive Biomarker in Metastatic CRPC

Frontline Therapy in Newly Diagnosed Metastatic HSPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Standard of Care in Metastatic Prostate Cancer

Adverse Effects of Hormone Therapy in Prostate Cancer

The Cardioprotective Role of Androgens

Further Therapeutic Strategies in Metastatic CRPC

Practical Applications of ERA 223 in the mCRPC Paradigm

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Redefining Advanced Prostate Cancer with Novel Imaging

Raoul S. Concepcion, MD, FACS, moderates this discussion with Daniel George, MD; Alec Koo, MD; Phillip Koo, MD; and Neal Shore, MD, FACS. The group of urologists and oncologists specializing in prostate cancer discusses redefining advanced prostate cancer with novel imaging.
View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval in Myeloma, Label Update in HER2+ Breast Cancer, Breakthrough Status in Prostate Cancer, and More